INTRODUCTION
Transcription factors are modular proteins where distinct functions, such as DNA binding, trans-activation or transrepression, are often contained within separable domains. DNA-binding domains tend to be particularly well conserved and can be used as the basis for a classification that reflects phylogenetic relationships. Transcription factors with the same basic design in their interaction with DNA also tend to be related in function and to share properties such as the ability to heterodimerize or to convey certain intracellular signals.
Forkhead proteins are not among the largest transcription factor families, but display a remarkable functional diversity and are involved in a wide variety of biological processes. The name derives from two spiked-head structures in embryos of the Drosophila fork head mutant, which are defective in formation of the anterior and posterior gut (Weigel et al., 1989) . With the discovery in 1990 of a 110-amino-acid DNA binding domain that was almost perfectly conserved between FORK HEAD and the mammalian HNF-3 transcription factors, it became clear that this motif defined a novel transcription factor family (Weigel and Jackle, 1990) . A comprehensive review on forkhead genes has been published by Kaufmann and Knochel (1996) .
EVOLUTION OF THE FORKHEAD GENE FAMILY
The decade that has passed since the discovery of the first members has seen the identification of many forkhead genes in a variety of eukaryotic organisms, and with the recent completion of several genome sequencing projects, it is now possible to make a preliminary assessment of the size and distribution of this gene family. Forkhead genes have so far only been found in opisthokont organisms (animals ϩ fungi), including several species of ascomycetic fungi and a wide variety of metazoans. Their absence in the Arabidopsis genome and failure to identify forkhead genes in any protist, support the view that this gene family is found exclusively in animals and fungi. Thus, the distribution of forkhead genes lends further support to opisthokonts as a well-defined evolutionary supergroup (Baldauf, 1999) . Mycetozoa (Myxozoa) have been classified as fungi or protists and more recently as metazoans (Siddall et al., 1995; Smothers et al., 1994) . However, the apparent lack of forkhead genes in Dictyostelium supports the recent reclassification of Mycetozoa as a separate clade close to, but distinct from, opisthokonts (Baldauf et al., 2000) . The involvement of forkhead proteins in many morphogenetic processes suggests that increasing complexity in body plan may have been a driving force behind the expansion of the forkhead gene family. Among the organisms for which the genome sequences are completed, or nearly so, there is indeed a correlation between anatomical complexity and forkhead gene number: 4 in Saccharomyces and Schizosaccharomyces, 15 in Caenorhabditis, 20 in Drosophila, and 39 in Homo.
NOMENCLATURE
In 2000, the nomenclature of chordate forkhead transcription factors was revised . The new nomenclature, which uses Fox (for "Forkhead box") as the root symbol, ensures that the same name is used for orthologous genes in different species and reflects phylogenetic relationships by including a letter that indicates subfamily. Within a subfamily, each gene is identified by a number (e.g., FoxF2), the typography follows the conventions used in each species (FOXF2 in Homo, Foxf2 in Mus, and FoxF2 in all others), and proteins are distinguished from genes by the use of roman type (e.g., FoxF2). New and old names, GenBank Accession Numbers, a phylogenetic tree, and other useful information can be found at the Web site http://www.biology.pomona.edu/fox.html. The most commonly used synonymes for human, mouse, and rat forkhead genes are listed in Table 1 .
THE FORKHEAD DOMAIN

3D Structure
Burley and co-workers used X-ray crystallography to work out the first 3D structure of a forkhead domain (FoxA3) bound to a DNA target. They compared the fold with the shape of a butterfly and coined the term "winged helix" to describe the structure, which has a helix-turn-helix core of three ␣-helices, flanked by two loops, or "wings" (Fig. 1) . "Winged helix" proteins are often used synonymously with forkhead proteins . However, several phylogenetically unrelated proteins have similar 3D structure and are referred to as winged helix proteins in the literature as well; e.g., MotA from bacteriophage T4, LexA from Echerichia coli, E2F, DP, and RFX transcription factors as well as double-stranded RNA adenosine deaminase, ADAR1 (reviewed by Gajiwala and Burley, 2000) . Care should be taken to distinguish between these topologically similar proteins of diverse evolutionary origin and forkhead proteins, which form a clearly defined, monophyletic group.
A large proportion of the amino acids in the forkhead domain are invariant or highly conserved (Fig. 1) , which implies that there is only limited variation in 3D structure and mode of DNA recognition within the forkhead family. This has been confirmed by NMR structural analysis of the DNA binding domains of three additional forkhead proteins: FOXC2, Foxd3, and FOXO4 (Jin et al., 1999; Marsden et al., 1998; van Dongen et al., 2000; Weigelt et al., 2001) . While Clark et al. (1993) identified three ␣-helices in FoxA3, the NMR structures all show a short fourth helix in the loop between helix 2 and 3. However, Weigelt et al. (2001) , point out that the backbone fold in this region is nearly identical in all four structures (including FoxA3) and inclusion or omission of a fourth helix mostly reflects differences in interpretation. A 5-amino-acid insertion between helix 2 and 3 found in the FoxO subfamily adds a small extra loop, but has surprisingly little effect on the overall structure (Weigelt et al., 2001 ). Binding to a DNA target site appears to cause only minor structural changes in the forkhead domain (Jin et al., 1999) , whereas circular permutation data indicate that a substantial bend is induced in the DNA (Pierrou et al., 1994) .
The structural basis for differences in sequence specificity between forkhead proteins remains elusive. Analysis of chimerical proteins identified regions close to the aminoterminal end of helix 3 Pierrou et al., 1994) and in the second wing (Pierrou et al., 1994) as important for specificity. The recognition helix of Foxd3 is tilted compared with the other three proteins for which the structures have been solved, and Liao and co-workers propose that this alters the sequence specificity (Jin et al., 1999; Marsden et al., 1998) . Wikströ m and collaborators argue that since FOXC2, FoxA3, and FOXO4 have close to identical 3D folds, variation in topology cannot generally explain distinct DNA binding specificities (van Dongen et al., 2000; Weigelt et al., 2001) , and instead propose differences in charge distribution in the protein-DNA interface as a possible cause (Weigelt et al., 2001) .
DNA Binding
In contrast to most helix-turn-helix proteins, forkhead proteins bind DNA as monomers. Hence, the binding sites, which typically span 15-17 bp, are asymmetrical. The sequence specificity has been determined for several representatives of this protein family through selection of binding sites from pools of short, random-sequence duplexes . A seven-nucleotide core corresponds to the major groove base contacts made by the recognition helix (helix 3). For the majority of forkhead proteins, the core conforms to the RYMAAYA (R ϭ A or G; Y ϭ C or T; M ϭ A or C) consensus Pierrou et al., 1994) , but the more distant outgroups also bind sequences with only partial match to this motif, e.g., the insulin response elements recognized by members of the FoxO subfamily (Brunet et al., 1999; ). An optimal core sequence is essential, but not sufficient for high affinity binding, which also depends on flanking sequences on both sides of the core Overdier et al., 1994; Pierrou et al., 1994; Roux et al., 1995) .
Distantly related forkhead proteins can have completely nonoverlapping sequence specificity due to preference differences in both core and flanking positions . Others have overlapping, but nonidentical target specificities, as shown for FOXC1 and FOXD1 (Pierrou et al., 1994) ; certain sequences are bound with equal affinity FIG. 1. Three-dimensional structure of the DNA-binding domains of FoxA3 bound to DNA (X-ray crystallography; Clark et al., 1993) and FoxC2 (NMR; van Dongen et al., 2000) . The FoxA3 structure shows the recognition helix (H3) filling out the major groove of DNA (viewing angle parallel with the H3 helical axis). The first wing (W1) reaches upward, approximately parallel with the DNA helical axis and beyond the (3Ј) end of the oligonucleotide, whereas the second wing (W2) makes minor groove contacts in the 5Ј end of the binding site. The FoxC2 NMR structure shows the helix-turn-helix motif viewed from the side facing away from the DNA with two helices, H1 and H2, stacked on top of the recognition helix (H3). The first wing (W1) consists of two antiparallel ␤-strands (yellow) separated by a short loop. In the bottom panel, alignment of 17 mouse forkhead domains illustrates the conserved regions in relation to helices (H1-H3) and ␤-strands (yellow).
by these two proteins, whereas others are preferentially bound by one or the other . Pairs or small groups of forkhead proteins have DNA binding domains so similar that the specificities have to be assumed to be identical; for example FOXD1 and FOXD2 have forkhead domains with 100% amino acid identity (Ernstsson et al., 1997) , and FOXC1 and FOXC2 are 97% identical . Mouse Foxf1, Foxf2, and human FOXF2 are 100% identical in the forkhead domain, whereas human FOXF1 differs by three conservative amino acid substitutions (Clevidence et al., 1994; Hellqvist et al., 1996; Miura et al., 1998; Pierrou et al., 1994) . This exceptional degree of sequence conservation is confined to the forkhead domain-in FOXD1 and -2, for example, there are no discernable homologies between the rest of the proteins. Since experimental data suggest that a considerable sequence variation within the forkhead domain can be tolerated with no or little effect on sequence specificity, additional interactions and functions are likely to contribute to the selective forces that preserve the forkhead domains.
Chromatin Remodeling
A winged helix fold remarkably similar to that of forkhead proteins, except for the lack of a second wing, is found in the linker histones H1 and H5 (Brennan, 1993; Cerf et al., 1994; Clark et al., 1993; Ramakrishnan et al., 1993) . A series of elegant papers from Zaret and co-workers suggest that this structural similarity is functionally significant. FoxA proteins can determine the positioning of nucleosomes in the albumin enhancer (McPherson et al., 1993 (McPherson et al., , 1996 Shim et al., 1998) ; they bind to DNA on one side of the nucleosome-in a manner similar to linker histones (Cirillo et al., 1998) -and more efficiently to DNA wrapped up in nucleosomes than to naked DNA (Cirillo and Zaret, 1999) . However, binding by FoxA1 does not compact chromatin, as linker histones do, but is instead correlated with an active chromatin structure in the albumin enhancer (Cirillo et al., 1998) . Furthermore, binding by FoxA proteins to nucleosomes is independent of histone acetylation and converts chromatin to a conformation where it can bind additional transcription factors (Cirillo and Zaret, 1999) . These data suggest that the forkhead domain can promote gene activation directly, by opening up chromatin, and not just by bringing in a separate transcriptional activation domain. Additional support for a role of forkhead proteins in regulation of chromatin structure comes from the observation that DOMINA (a Drosophila protein most closely related to the FoxN subfamily) can suppress position-effect variegation, i.e., the position-dependent silencing of genes through spreading of heterochromatin (Strodicke et al., 2000) .
Nuclear Localization
The sequences responsible for nuclear localization have been mapped in FoxA2 and FOXF2 (Hellqvist et al., 1998; Qian and Costa, 1995) . In both proteins, the NLS is contained within the forkhead domain; sequences from its amino-and carboxy-terminal end have NLS activity, and both of these regions are needed for efficient nuclear localization. The carboxy-terminal part of this bipartite NLS consists of a cluster of basic amino acids, characteristic of many NLS motifs, but the amino-terminal part does not. The high degree of sequence conservation among forkhead domains suggests that this NLS structure is valid for all family members. However, in the FoxO subfamily, the NLS is regulated; subcellular localization is controlled by phosphorylation in response to extracellular signals (see below; Biggs et al., 1999; Brunet et al., 1999; Cahill et al., 2000) .
TRANSCRIPTIONAL EFFECTOR DOMAINS
Forkhead proteins have been shown to act mostly as transcriptional activators but not exclusively so. For example, trans-repression has been reported for FoxC2, -D2, -D3, and -G1 (Bourguignon et al., 1998; Sutton et al., 1996) . In C. elegans, the forkhead protein LIN-31 is thought to act as either repressor or activator, depending on its phosphorylation in response to MAP kinase signaling (Tan et al., 1998) . Mammalian FoxG1 represses transcription by forming a complex with transcriptional co-repressors of the Groucho family and histone deacetylases (Yao et al., 2001) . Specific binding to Groucho proteins has also been reported for FoxA2 (Wang et al., 2000) .
Using deletions and substitutions, the regions that contribute to transcriptional activation have been mapped in detail for several forkhead proteins, such as FoxA2, -F1, -F2, -N1, and others (Hellqvist et al., 1998; Mahlapuu et al., 1998; Pani et al., 1992; Qian and Costa, 1995; Schuddekopf et al., 1996) . Like many other transcription factors, forkhead proteins often contain several activating regions, and these can be found in any location relative to the DNA binding domain.
The high degree of sequence homology within the DNA binding domain contrasts with the almost total lack of similarity between activation or repression domains in different forkhead proteins. Only within certain subfamilies can conservation of short activating motifs be recognized, e.g., "region II" in the FoxA subfamily (including FORK HEAD from Drosophila) (Clevidence et al., 1994) and the C-terminal trans-activation domains in the FoxF subfamily (Hellqvist et al., 1998; Mahlapuu et al., 1998) . In general, the described trans-activation and -repression domains lack distinctive features, such as enrichment for a particular amino acid. An exception is the C-terminal activation domain of Foxn1, which appears to be a typical "acidic blob" .
Little is known about the mechanisms through which forkhead proteins interact with the transcriptional machinery. In vitro, FOXF2 binds the general transcription factors TBP and TFIIB, and in cotransfection experiments, FOXF2 acts synergistically with TFIIB (Hellqvist et al., 1998) .
CHROMOSOMAL LOCALIZATION AND GENOMIC ORGANIZATION
In general, forkhead genes are distributed throughout the genomes and do not form physically linked clusters. Proximity, suggesting recent duplication, is seen in some pairs of closely related genes; for example, the Drosophila genes sloppy paired 1 and 2 (slp 1, 2) map within 10 kb (Grossniklaus et al., 1992) . Human FOXC1 and FOXF2 are located in the same region of chromosome 6 (6p25), whereas FOXC2 and FOXF1 are close on chromosome 16 (16q24) Kaestner et al., 1996; Larsson et al., 1995) . The mouse orthologs are organized in a similar way (Avraham et al., 1995; Chang and Ho, 2001; Hong et al., 1999; Kaestner et al., 1996; Labosky et al., 1996) . A possible interpretation of this arrangement is that duplication of a primeval gene-followed by divergence of the two copiesgave rise to ancestral FoxC and FoxF genes (Fig. 2) . A more recent duplication of the entire locus, transfer of one copy to a different chromosome, and additional sequence divergence then gave rise to the present four genes. The last duplication apparently took place after the separation of protostomes and deuterostomes; in Drosophila, there is just one homolog each of FoxC (corocodile) and FoxF (biniou). In C. elegans, the situation is less clear, but an obvious FoxC homolog is missing and the FoxF homolog, F26B1.7, is among those most similar to FoxC/crocodile. Thus, the first (hypothetical) duplication may have coincided with the appearance of primitive coelomate animals. Evidently, evolution has found independent uses for all four mammalian genes, since knockout in mouse of any of these results in embryonic lethality Kume et al., 1998; Mahlapuu et al., 2001b; N. Miura, personal communication) . Nevertheless, overlaps in function have also been retained, as shown by the severe defects in combined Foxc1/c2 (Kume et al., 2000b (Kume et al., , 2001 and Foxf1/f2 (M. Ormestad, N. Miura, and P. C., unpublished observations) mutants.
The genomic organization of forkhead genes varies, but locations of introns are usually conserved in orthologs from different species and between closely related genes. Most of the vertebrate genes are comparatively small with few introns. Quite a few are intronless (e.g., FoxC1, -C2, -D1, -D2, -D4, -E3, and -G1) (Blixt et al., 2000; Hatini et al., 1996; Kaestner et al., 1995; Miura et al., 1997; Xuan et al., 1995) , whereas in others the forkhead box is interrupted by an intron, e.g., FoxII, -J1, and -N1 (Brody et al., 1997; Clevidence et al., 1993; Murphy et al., 1997; Pierrou et al., 1994; Schorpp et al., 1997) . In FOXO1 and -O3, the intron that splits the forkhead box is particularly large, 90 and 130 kb, respectively (Anderson et al., 1998) , which is probably an important reason why translocations with breakpoints in this intron are such a common cause of alveolar rhabdomyosarcoma (see below). FoxF genes are interrupted by an intron 3Ј of the forkhead box Chang and Ho, 2001; Mahlapuu et al., 1998; Miura et al., 1998) , whereas FoxA genes have one or two introns on the 5Ј side (Kaestner et al., 1994) .
FoxA3, -C1, -D1, and -D4 are transcribed from conventional TATA promoters (Ernstsson et al., 1996; Kaestner et al., 1994 Kaestner et al., , 1995 Mears et al., 1998) , but no TATA-box is located near the transcription start in FoxA1, -F1, -F2, or J1. Instead, CpG islands surround the transcription start regions of these genes Brody et al., 1997; Kaestner et al., 1994; Mahlapuu et al., 1998) .
Several forkhead genes, such as FoxC1, -K1, -M1, -N1, and P3, give rise to multiple mRNAs, due to alternative start or polyadenylation sites, or to differential splicing of primary transcripts Nishimura et al., 1998; Schorpp et al., 1997; Yang et al., 1997; Ye et al., 1997) .
The human genome also contains a few intronless sequences related to FOXO genes, FOXO1b and FOXO3b, that appear to be processed pseudogenes (Anderson et al., 1998) .
FORKHEAD PROTEINS AND SIGNAL TRANSDUCTION
TGF␤-Smad
FoxH1 is an important inducer of mesoderm specification (Watanabe and Whitman, 1999) . It was first identified as a protein that binds to an activin response element in the promoter region of the mesoendodermal homeobox gene Mix.2 (Chen et al., 1996) . In the absence of activin signaling, FoxH1 binds constitutively, but does not activate transcription (Fig. 3A) . In the presence of activin-a member of the TGF␤ superfamily-a complex containing FoxH1, Smad2, and Smad4 assembles on the DNA and transcription is activated (Chen et al., 1996 (Chen et al., , 1997 Liu et al., 1999; Yeo et al., 1999) . Mammalian FoxH1 homologs have been identified and also mediate TGF␤-type signaling through interaction with activated Smads (Labbe et al., 1998; Weisberg et al., 1998; Zhou et al., 1998) . Mouse embryos without Foxh1 do not respond to nodal signaling and have defects in the node and anterior primitive streak (Hoodless et al., 2001; Yamamoto et al., 2001) . In contrast to FoxH1, FoxG1 inhibits TGF␤-type signaling (Dou et al., 2000; Rodriguez et al., 2001 ). The inhibition is independent of the FoxG1 DNA binding domain, and according to Dou et al. (2000) , the mechanism consists of an inhibitory interaction between FoxG1 and FoxH1. Rodriguez et al. (2001) , on the other hand, found that the C-terminal part of FoxG1 binds to the MH2 domain of Smads and inhibits their association with DNA.
MAP Kinase
The C. elegans forkhead protein LIN-31 (Miller et al., 1993 (Miller et al., , 2000 ) is a nuclear target for a receptor tyrosine kinase/RAS/MAPK signaling cascade in vulval precursor cells (Tan et al., 1998) . The inductive signal is encoded by the lin-3 gene, which is related to epidermal growth factor (EGF). The receptor for this ligand is the let-23 product, which is a tyrosine kinase of the EGF receptor family. Interaction between LIN-3 and LET-23 leads to activation of RAS/MAP kinase signaling (reviewed by Kornfeld, 1997) . LIN-31 and ETS transcription factor LIN-1 physically interact when unphosphorylated and inhibit vulval fates. Upon MAP kinase phosphorylation, the LIN-31/LIN-1 complex is disrupted, and phosphorylated LIN-31 then acts as a transcriptional activator, promoting the expression of vulval genes (Tan et al., 1998) .
Akt/PKB
Forkhead proteins of the FoxO subfamily are targets for PI3K/PDK1/PKB signaling initiated by insulin or insulinlike growth factor I receptors (for reviews, see Brunet et al., 2001; . FoxO proteins regulate transcription of target genes involved in metabolism, but also mediate the survival factor function of growth factors by controlling expression of apoptosis genes, such as FasL.
The initial clues about a connection between insulin-like signaling and forkhead transcription factors came from the nematode C. elegans. Inactivation of the C. elegans daf-2 gene, which encodes a homolog of the insulin receptor, causes animals to arrest as dauers, shifts metabolism to fat storage, and prolongs the life span of the worm (Kenyon et al., 1993; Kimura et al., 1997) . Mutations in the FoxO homolog daf-16 suppress the dauer arrest, the metabolic shift, and the longevity phenotypes of daf-2 mutants, indicating that DAF-16 is a negatively regulated target of C. elegans insulin receptor-like signaling (Lin et al., 1997; Ogg et al., 1997) . DAF-16 is negatively regulated by DAF-2 through phosphorylation via AGE-1 (PI3K-like protein), PDK-1 (homolog of the mammalian PDK1), and AKT1/ AKT2 (PKB-like kinases) (Morris et al., 1996; Paradis et al., 1999; Paradis and Ruvkun, 1998) . This signaling pathway has been conserved between worm and mammals, where the homologs of DAF-16 -FoxO1, FoxO3, and FoxO4 -are targets for P13K/PKB phosphorylation (Brunet et al., 1999; Rena et al., 1999; Takaishi et al., 1999; Tang et al., 1999) . PKB/AKT inhibits transcriptional activation by FoxO/DAF-16 proteins through control of subcellular localization; when phosphorylated, FoxO/DAF-16 relocate from the nucleus to the cytoplasm through interaction with 14-3-3 proteins (Biggs et al., 1999; Brunet et al., 1999; Cahill et al., 2000; Henderson and Johnson, 2001; Lee et al., 2001; Lin et al., 2001) . Mutation of the AKT phosphorylation sites in DAF-16 leads to its stable nuclear localization, independent of DAF-2 signaling; Lee et al. (2001) found this to correlate with a constitutive dauer phenotype in a daf-2ϩ background, whereas Lin et al. (2001) failed to see an effect on either life span or dauer formation. Hence, there is still controversy as to whether regulation of DAF-16 nuclear localization through phosphorylation by AKT is the only output of DAF-2 signaling, or whether other mechanisms act in parallel. Under dauer-inducing conditions, daf-7-encoding a TGF-␤-like ligand-also affects DAF-16 localization, which suggests DAF-16 as an integration point for insulin-and TGF-␤-like pathways Ogg et al., 1997) .
Inhibition of FoxO proteins by PI3K/PKB is necessary for cell cycle entry in G 1 (Jones et al., 1999; Klippel et al., 1998; Medema et al., 2000) , but reactivation in G 2 is essential for proper G 2 /M, M/G 1 transitions and cytokinesis (Alvarez et al., 2001) . FoxO4 can also be phosphorylated by a PKB-independent mechanism that requires Ras signaling Medema et al., 2000) , which further emphasizes the role of forkhead proteins as crossroads for different signaling pathways.
Hedgehog
Several mammalian forkhead genes depend on the Hedgehog-Patched (Ptch)-Smoothened (Smo)-Gli signaling pathway for their expression. Sonic hedgehog (Shh) secreted from the notochord induces expression of Foxa2 in the floorplate of the neural tube and Foxa2 maintains Shh expression in a positive feedback loop (Chiang et al., 1996; Echelard et al., 1993; Hynes et al., 1997; Sasaki et al., 1997) . Foxc2 and Foxd2 are induced in presomitic mesoderm by Shh from the notochord (Furumoto et al., 1999; Wu et al., 1998) . Expression of Foxf1 in lung and foregut mesenchyme and in sclerotomes depends on Shh signaling from endodermal epithelia and notochord, respectively (Mahlapuu et al., 2001a) . In embryos lacking Shh, residual Foxf1 expression is
FIG. 2.
A model for evolution of FoxF and FoxC genes from a common ancestor based on sequences, exon-intron distribution, chromosomal localization, expression patterns, and mutant phenotypes. C. elegans has a single gene that appears to be the ancestor of both FoxC and FoxF genes and which is involved in muscle differentiation. In animals with a true coelom, distinct FoxC and FoxF genes are present in both protostomes and deuterostomes. The duplication of a common ancestor gene, followed by divergent evolution to generate FoxC and FoxF, is therefore likely to have occured prior to, or soon after, the appearance of primitive coelomate animals. Since the FoxF genes in both mammals and Drosophila are involved in differentiation of the visceral/splanchnic mesoderm, whereas FoxC genes are restricted to nonvisceral mesoderm, it is possible that functional divergence of FoxC and FoxF was intimately connected to the evolution of the coelom. An additional duplication has taken place in the deuterostome lineage, and signs of this can still be seen in the human genome, where FoxC1 and FoxF2 are located close to each other on chromosome 6, while FoxC2 and FoxF1 are adjacent on chromosome 16. C. elegans picture courtesy of Catarina Mö rck. seen in mesoderm of the hindgut and yolk sac (Mahlapuu et al., 2001a) , which neighbor sites of Indian hedgehog secretion (Bitgood and McMahon, 1995; Farrington et al., 1997; Maye et al., 2000) .
Wnt
Foxl1 knockout mouse embryos develop severe structural defects in the gastrointestinal tract due to overproliferation of the intestinal epithelium (Kaestner et al., 1997) . The hyperproliferation correlates with activation of the Wnt/␤-catenin/TCF signaling pathway (Perreault et al., 2001) , which is important for the control of intestinal epithelial proliferation and the dysregulation of which is a major cause of human colorectal cancers. Rather than affecting the signal-transducing intracellular components, the normal function of Foxl1-which is expressed in the intestinal mesenchyme-appears to be to restrict deposition of the Massague, 1998) . The activated type I receptor then directly interacts with and phosphorylates the receptorregulated Smad, Smad2. Phosphorylation of Smad2 stimulates its interaction with the common Smad, Smad4, and the transport of the resulting heteromeric complex to the nucleus (reviewed by Attisano and Wrana, 2000; Wrana and Attisano, 2000) . In the absence of activin signaling, FoxH1 binds constitutively to an activin response element in the promoter region of the Mix.2 gene, but does not activate transcription. In the presence of activin, the Smad2/Smad4 complex translocates to the nucleus and is recruited by FoxH1 to the promoter of Mix.2, which leads to activation of transcription (Chen et al., 1996 (Chen et al., , 1997 . Analysis of the FoxH1/ Smad complex shows that Smad2 interacts directly with FoxH1 and brings Smad4 into the complex. Smad4 then binds DNA at a site adjacent to the FoxH1 binding site and stabilizes the Smad/ FoxH1/DNA complex . (B) Model for forkhead protein LIN-31 function in vulval development of C. elegans. LIN-3, a protein similar to EGF, is produced by gonadal anchor cell and initiates vulval development by activating the EGF receptor tyrosine kinase homolog LET-23 in the closest vulval precursor cell. Activation of the LET-23 triggers a conserved Grb2/Ras/Raf/ MEK/MAP kinase cascade, the components of which are encoded by genes sem-5, let-60, lin-45, mek-2, and mpk-1, respectively (reviewed by Kornfeld, 1997) . If the MAP kinase is inactive in cells, the LIN-1/LIN-31 complex binds to the promoter of target genes and represses transcription. Active MAP kinase enters the nucleus and directly phosphorylates both LIN-1 and LIN-31 proteins. Phosphorylation of LIN-31 disrupts the LIN-1/LIN-31 complex, and phosphorylated LIN-31 acts as a transcriptional activator, promoting vulval cell fates (Tan et al., 1998) . (C) Model for phosphorylation-dependent inhibition of forkhead protein DAF-16-activated transcription in C. elegans. Activation of DAF-2 receptors triggers a conserved signaling cascade in the worm involving AGE-1, PDK-1, and AKT1, -2 proteins (homologs of the mammalian PI3K, PDK1, and PKB, respectively) (reviewed by . Activated AKT kinases move to the nucleus and phosphorylate the DAF-16 protein, which results in redistribution of DAF-16 from the nucleus to the cytoplasm and in inhibition of target gene expression (Cahill et al., 2000; Henderson and Johnson, 2001 ; Lee et al., 2001; Lin et al., 2001) . extracellular proteoglycans which act as coreceptors for Wnt.
Cell Cycle Regulation
The yeast forkhead proteins Fkh1 and Fkh2 regulate the expression of the CLB2 cluster genes, whose transcription peaks early in mitosis (Spellman et al., 1998; Zhu et al., 2000) . Fkh1 and Fkh2 are constitutively bound to promoters of CLB2 cluster genes, in complex with the MADS-box protein Mcm1, and function by providing a permanent platform for further regulatory inputs (Futcher, 2000; Lydall et al., 1991; Pic et al., 2000) . One of these regulatory proteins recruited by the Mcm1-Fkh complex in the G 2 /M phase is Ndd1, which is needed for activation of transcription (Koranda et al., 2000) . The Fkh proteins are phosphorylated in a cell cycle-dependent manner, which may control activation of the Mcm1-Fkh-Ndd1 complex (Pic et al., 2000) . In vivo, Fkh1 and Fkh2 occupy different promoters, and in vitro data suggest that they differ in their ability to bind synergistically with Mcm1 (Hollenhorst et al., 2001) .
In mammals, expression of the forkhead gene FoxM1 is confined to cycling cells and is regulated in a cell cycledependent manner, with activation upon entry into S phase (Korver et al., 1997) . FoxM1 is phosphorylated in M phase, which implies regulation at both transcriptional and protein levels. Inactivation of Foxm1 in mice leads to uncoupling between S phase and mitosis, with polyploidy as a result (Korver et al., 1998) . Its function therefore appears to be prevention of DNA re-replication during the G 2 and M phases.
FoxO4, which is negatively regulated by growth factors (see above), blocks cell-cycle progression at G 1 , independent of the retinoblastoma protein, by transcriptional activation of the cdk inhibitor p27 kip1 (Medema et al., 2000) .
The Forkhead Associated (FHA) Domain
The FHA domain was discovered as a region of sequence homology between a set of proteins that includes, but is not restricted to, four forkhead proteins, Fhl1, Fkh1, and -2 from Saccharomyces and mammalian FoxK1 (Hofmann and Bucher, 1995) . It contains three conserved blocks of amino acids separated by more divergent spacer regions, which make the total size variable. Most of the proteins that contain the FHA domain are nuclear and involved in cell cycle, checkpoint control, or signal transduction (e.g., Rad53, Fkh1, -2, Dun1, Spk1, Ki67, Mek1, Chk2). The FHA domain binds proteins phosphorylated on serine or threonine and mediates protein-protein interactions (Durocher et al., 2000; Li et al., 2000) ; i.e., it is for phosphoserine and phosphothreonine what the SH2 domain is for phosphotyrosine. In contrast to the forkhead domain, the FHA domain is present in several Arabidopsis proteins and thus appears to be a more ancient evolutionary invention.
FORKHEAD GENES IN DEVELOPMENT
This overview of embryonic development focuses on vertebrates. Although the pioneering work that indicated a role for forkhead genes in early patterning was performed in Xenopus (Dirksen and Jamrich, 1992; Knochel et al., 1992; Ruiz i Altaba and Jessell, 1992) , the emphasis in this account reflects the recent advances based on work with mutant mice (Table 2) . Where functions appear to have been conserved, comparisons are made with invertebrates. The first documented roles of forkhead genes in vertebrate development are in defining different populations of mesoderm immediately following gastrulation.
As described in the signal transduction section, FoxH1 functions as a Smad DNA-binding partner to regulate transcription in response to activin and nodal signaling. Deletion of Foxh1 in mice partly phenocopies loss of nodal and results in failure to pattern the anterior primitive streak, to form node, prechordal mesoderm, notochord, or definitive endoderm (Hoodless et al., 2001; Yamamoto et al., 2001) . Expression of Foxa2 in the node is dependent on Foxh1 (Hoodless et al., 2001) and, like the Foxh1 mutant, Foxa2 null embryos lack notochord (Ang and Rossant, 1994; Weinstein et al., 1994) . The notochord is an important midline signaling center that secretes sonic hedgehog, and its absence in Foxa2 null embryos leads to lack of floorplate and defects in dorsoventral patterning of the neural tube and somites.
Indirect evidence suggests that a third forkhead gene, Foxj1, is required for proper function of the node. Left-right asymmetry in the vertebrate embryo is initiated in the node and requires hedgehog signaling (Levin et al., 1995; Zhang et al., 2001) . The asymmetric distribution of lateralizing signals requires cilial movements within the node (Nonaka et al., 1998) , and several observations implicate Foxj1 in this process; it is expressed in ciliated node cells and Foxj1 null mice have randomized left-right asymmetry (Brody et al., 2000; Chen et al., 1998) . Although cilia are not absent in Foxj1 Ϫ/Ϫ node cells, the defective cilia in airway epithelial cells in the same mutant and ectopic ciliogenesis caused by forced Foxj1 expression (Tichelaar et al., 1999) show that this forkhead gene is important for cilial function. Nascent mesodermal cells formed in different regions of the primitive streak differentiate into distinct populations along the mediolateral axis (corresponds to the dorsoventral axis of later stages) of the embryo, and each population expresses its characteristic subset of forkhead genes (Fig. 4) . As described above, Foxa2 is expressed in the anterior end of the primitive streak-the node-and specifies axial mesoderm (notochord). Four forkhead genes-Foxb1, -c1, -c2, and -d2-are expressed in the paraxial mesoderm, and in somites, their mRNAs occupy distinct, but overlapping, regions. Foxb1 is expressed in the dorsal somite, but all somite-derived structures are negative for Foxb1 expression at later stages (Labosky et al., 1997) . Foxc1 and -c2 are expressed throughout and Foxd2 in the ventral region of epithelial somites; mRNA for these three genes becomes restricted to the sclerotome as the somites differentiate further , 2000a . Foxc1 and -c2 are functionally redundant in the presomitic mesoderm. Although both null mutants are embryonically lethal with vascular and skeletal malformations Kume et al., 1998; Winnier et al., 1997) , neither exhibits any overt defects in somitogenesis. The compound homozygotes, however, lack somites and segmentation of the paraxial mesoderm (Kume et al., 2001 ). In the absence of Foxc1 and -c2, transcription of paraxis, Mesp1 and -2, Hes5, and Notch1 is lost in the anterior presomitic mesoderm, as is the formation of sharp boundaries of Dll1, Lfng, and ephrinB2 expression. Foxc1 and -2 thus appear to interact with the Notch-Delta signaling pathway in the prepatterning of anterior and posterior domains of the presumptive somites (Kume et al., 2001) . Foxd2 homozygous null mice have no major developmental defects in somite derivatives (Kume et al., 2000a) , and only a minority of Foxb1 mutants Blixt et al., 2000; Brownell et al., 2000 Foxf1 (FREAC1,
HFH-8)
Die around E9 due to absence of vasculogenesis in yolk sac and allantois as a result of defects in mesodermal differentiation. Heterozygotes have lung and foregut malformations. Kalinichenko et al., 2001; Mahlapuu et al., 2001a,b Foxg1 (Bf1) Die around birth, with a severe reduction in the size of the cerebral hemispheres.
Xuan et al., 1995
Foxh1 (Fast) Embryonically lethal due to failure to form node, prechordal mesoderm, notochord, and definitive endoderm. Hoodless et al., 2001; Yamamoto et al., 2001 Foxi1 (Fkh-10) Malformations of the inner ear results in deafness and disturbed balance. Hulander et al., 1998 Foxj1 (HFH-4) Majority die before weaning and show defective ciliogenesis as well as randomized left-right asymmetry. Brody et al., 2000; Chen et al., 1998 Foxk1 (MNF) Viable, but growth retarded. Incomplete muscle regeneration after injury due to defect proliferation and differentiation of myogenic stem cells.
Garry et al., 2000
Foxl1 (Fkh-6) The majority die before weaning with intestinal epithelial hyperplasia due to overactivation of the Wnt/␤-catenin pathway. Kaestner et al., 1997; Perreault et al., 2001 Foxm1 (Trident, HFH-11) Die perinatally with cardiovascular defects and polyploidy in cardiomyocytes and hepatocytes. Korver et al., 1998 Foxn1 (Whn) Exhibit all features of the original nude mutant, such as hairlessness and athymia. Nehls et al., 1994 Nehls et al., , 1996 Foxp3 (scurfy mutant) Overproliferation of CD4 ϩ CD8 Ϫ T lymphocytes, extensive multiorgan infiltration and elevation of cytokines.
Jeffery et al., 2001
Foxq1
(satin mutant) Have a silky fur coat due to defects in differentiation of the hair shaft. show a reduction of the posterior part of the body that may be related to its expression in presomitic mesoderm (Labosky et al., 1997) . The posterior primitive streak and lateral plate mesoderm express Foxf1, and laterally the expression continues into the extraembryonic mesoderm of amnion, allantois, and yolk sac (Mahlapuu et al., 2001b; Peterson et al., 1997) . In extraembryonic mesoderm, inactivation of Foxf1 leads to ubiquitous expression of the cell adhesion molecule VCAM1, with the result that VCAM1 is coexpressed with its ligand, ␣4-integrin (Mahlapuu et al., 2001b) . This is likely to contribute to the enhanced intramesodermal cohesion that prevents affected extraembryonic structures from expanding or reshaping, and to the abnormal adherence or fusion between amniotic and yolk sac mesoderm of Foxf1 Ϫ/Ϫ embryos. Foxf1 promotes the division of the lateral plate into splanchnic and somatic mesoderm, and as differentiation proceeds, Foxf1 expression becomes confined to the splanchnopleure (Mahlapuu et al., 2001b) . In Foxf1 null embryos, the splanchnic mesoderm fails to separate completely from the somatic and expresses a marker for somatic mesoderm, the homeobox gene Irx3. The core function of FoxF genes in mesoderm differentiation has been conserved between vertebrates, Drosophila and C. elegans (Fig. 2) . The Drosophila FoxF homolog biniou (bin) controls development of the visceral mesoderm (corresponds to the splanchnic mesoderm in vertebrates) and the derived gut musculature (Zaffran et al., 2001) . As in Foxf1 Ϫ/Ϫ mouse embryos, there is a conversion of visceral to somatic mesoderm in the bin mutant. Conversely, ectopic expression of bin in the somatic mesoderm leads to activation of visceral mesoderm markers (Zaffran et al., 2001) . In C. elegans, the FoxF homologue, F26B1.7, is essential for normal development of several muscle types (M. Hellqvist, personal communication). Mouse Foxf1 is required for normal expression of Bmp4 in ventral (lateral) mesoderm (Mahlapuu et al., 2001b) , and in Drosophila, the same relation exists between biniou and decapentaplegic (dpp) (Zaffran et al., 2001) , although here it is expressed dorsally, consistent with the inversion of the dorsoventral axis between chordates and arthropods. Also in C. elegans is a TGF␤-like ligand, UNC-129, responsible for dorsoventral patterning, and a forkhead protein, UNC-130, establishes the gradient by inhibiting unc-129 expression ventrally (Nash et al., 2000) .
The vertebrate endoderm expresses several forkhead genes, e.g., Foxa1, -2, and -3. Formation of the epithelial gut tube requires Foxa2-the definitive endoderm is formed in Foxa2 Ϫ/Ϫ embryos, but foregut morphogenesis is severely affected (Ang and Rossant, 1994; Weinstein et al., 1994) . A role for this class of genes in differentiation of the anterior gut appears to be an ancient feature in metazoan development; the FoxA ortholog in Drosophila, forkhead, is essential for morphogenesis of the anterior digestive tract (Weigel et al., 1989) , and in C. elegans, the closest relative of FoxA genes is pha-4, which specifies the cells of the pharynx (Gaudet and Mango, 2002; Horner et al., 1998; Kalb et al., 1998) . During organogenesis in the mouse embryo, additional forkhead genes are involved in differentiation of specialized local epithelia that evaginate or migrate from the primitive gut and give rise to different organs. Foxe1 is expressed in the foregut epithelium and the migrating thyroid precursor cells; null mutations in this gene cause thyroid agenesis in both mouse and man (Clifton-Bligh et al., 1998; De Felice et al., 1998; Macchia et al., 1999) . The product of the nude mouse gene, Foxn1 (Nehls et al., 1994) , is expressed in the precursor cells of the thymic epithelium and is essential for their differentiation into the subcapsular, cortical, and medullary epithelial cells of the thymus (Nehls et al., 1996) . Foxa1 and -2 regulate gene expression in the lung epithelium (reviewed by Costa et al., 2001) ; Foxj1 specifies the ciliated cells in the proximal airway epithelium (Brody et al., 2000; Chen et al., 1998; Tichelaar et al., 1999) and Foxp2 is preferentially expressed in the distal cells (Shu et al., 2001) .
Nonendodermal epithelia require other forkhead proteins for proper function. Foxe3 promotes proliferation and blocks premature differentiation of the ectodermally derived lens epithelial cells (Blixt et al., 2000) . It is also required for closure of the lens vesicle and survival of the anterior lens epithelium (Blixt et al., 2000; Brownell et al., 2000) . Foxi1 is expressed in the mesodermal epithelium of the distal renal tubuli and in the ectodermal epithelium of the otic vesicle (Hulander et al., 1998) . Homozygous Foxi1 null mice are deaf and circle due to a severe malformation of the vestibulum and cochlea in the inner ear (Hulander et al., 1998) .
Mesodermally expressed forkhead genes participate in the epitheliomesenchymal cross talk and frequently influence the development and differentiation of associated epithelia. Foxl1 is expressed in the gut mesenchyme and controls the proliferation of the intestinal epithelium by interfering with growth factor signaling (Kaestner et al., 1997; Perreault et al., 2001) . Foxf1 is expressed in the lung mesenchyme in response to sonic hedgehog signaling from the epithelium (Mahlapuu et al., 2001a) , and Foxf1 heterozygotes exhibit lung hypoplasia, defects in branching morphogenesis, and disruption of the tight association between endothelial and epithelial cells Mahlapuu et al., 2001a) . Foxd1, which is expressed in the stromal cells of the kidney, controls the production of signals that are required for the normal transition of induced mesenchyme into tubular epithelium and growth and branching of the collecting system (Hatini et al., 1996) . Foxd2 is also expressed in the developing kidney (Wu et al., 1998) and some Foxd2 null mutants have kidney hypoplasia and hydroureter (Kume et al., 2000a) . Foxk1 is expressed selectively in myogenic stem cells (satellite cells) in adult mice. Skeletal muscles of Foxk1 Ϫ/Ϫ animals are atrophic, and timing of expression of cell cycle regulators and myogenic determination genes is dysregulated.
In the neuroectoderm, Foxg1 is essential for development of the cerebral hemispheres (Xuan et al., 1995) . Telencephalic neuroepithelial cells are specified in the Foxg1 mu-tant, but their proliferation is reduced and premature differentiation leads to early depletion of the progenitor population. FoxG1 is also, together with FoxD1, involved in topographical mapping of retinal neurons on the tectum (Yuasa et al., 1996) . The temporal part of the retina expresses FoxD1 and the nasal FoxG1. Misexpression of either gene causes misprojection of retinal neurons on the tectum along the rostrocaudal axis (Yuasa et al., 1996) . The closest homolog of FoxD1 in C. elegans, unc-130, also controls neuronal fates (Sarafi-Reinach and Sengupta, 2000) , and in Drosophila, JUMEAUX determines the distinct cellular identities of two sibling neurons in the central nervous system (Cheah et al., 2000) . FoxD3 promotes differentiation of neural crest from neural tube progenitors and appears to act downstream of Pax3 and independent of Slug (Dottori et al., 2001; Kos et al., 2001; Sasai et al., 2001) . In neural crest, FoxD3 inhibits melanoblast development and thereby facilitates differentiation of other neural crest-derived cell types (Kos et al., 2001) . Foxc1 is expressed in mesenchyme derived from the cephalic neural crest; the null mutant has hydrocephalus and defects in chondrogenesis, skeletal, and eye development (Hong et al., 1999; Kume et al., 1998) . The FoxC homolog in Drosophila, CROCODILE, controls patterning of the anterior-most head segment primordium and development of head skeletal structures (Hacker et al., 1995) .
Two forkhead genes, Foxn1 and -q1, are important for mammalian hair follicle development. Satin mice have a defect in hair shaft formation, which has been linked to mutations in Foxq1 (Hong et al., 2001) . Foxn1 promotes proliferation and inhibits differentiation of hair follicle epithelial cells (Brissette et al., 1996; Prowse et al., 1999) . This mode of action, which leads to a hypoplastic mutant phenotype due to depletion of precursor cells, is very similar to that of Foxe3 in the lens and Foxg1 in the telencephalon.
FORKHEAD MUTATIONS IN HUMAN DISEASE
Developmental Genetic Disorders
Analysis of mutant phenotypes in mice has facilitated identification of mutations in human forkhead genes that cause congenital malformations. So far, mutations in eight different forkhead genes have been associated with human developmental disorders, including immune, skeletal, circulatory, and craniofacial defects (Table 3) . Notably, four of the disorders include eye abnormalities. Mutations in FOXC1 and -E3 have been identified in patients with defects in development of the anterior chamber of the eye (Lehmann et al., 2000; Mears et al., 1998; Mirzayans et al., 2000; Nishimura et al., 1998 Nishimura et al., , 2001 Ormestad et al., 2002; Semina et al., 2001) . Mutations in FOXL2 cause variable eyelid defects, sometimes associated with ovarian failure (Crisponi et al., 2001; De Baere et al., 2001) , and mutations in FOXC2 lead to distichiasis, or double rows of eyelashes, together with lymphedema (Bell et al., 2001; Erickson, 2001; Fang et al., 2000; Finegold et al., 2001 ).
An intriguing spectrum of symptoms is exhibited by persons with mutations in FOXP2 . Affected individuals have a severe impairment of the selection and sequencing of fine orofacial movements, which are necessary for articulation. They have also deficits in language processing-such as the ability to break up words into phonemes-and grammatical skills, including comprehension of syntactical structure. Some have a nonverbal IQ close to the population average, which suggests that FOXP2 Lehmann et al., 2000; Mears et al., 1998; Mirzayans et al., 2000; Nishimura et al., 1998 Lymphedema combined with distichiasis, ptosis and/or cleft palate
Autosomal dominant Fang et al., 2000; Finegold et al., 2001 FOXE1 Thyroid agenesis, cleft palate, and choanal atresia Autosomal recessive Clifton-Bligh et al., 1998 FOXE3 Malformations in the anterior segment of the eye including Peters' anomaly Autosomal dominant Ormestad et al., 2002; Semina et al., 2001 FOXL2 Blepharophimosis/ptosis/epicanthus inversus syndrome (BPES); can be associated with ovarian failure (BPES type I)
Autosomal dominant Crisponi et al., 2001; De Baere et al., 2001; Prueitt and Zinn, 2001 FOXN1 T cell immunodeficiency combined with alopecia and dystrophic nails Autosomal recessive Frank et al., 1999 
FOXP2
Severe speech and language disorder Autosomal dominant Lai et al, 2001 FOXP3 Immune dysregulation, polyendocrinopathy, enteropathy syndrome (IPEX) X-linked recessive Bennett et al., 2001; Ramsdell et al., 2001 is only essential for neural mechanisms specifically involved in language and speech development. The majority of mutations in forkhead genes that have been linked to developmental disorders in humans are substitutions or frameshifts that disable or remove the DNA binding domain. They are therefore, most likely, loss-of-function alleles. Defects due to mutations in FOXE1 (thyroid agenesis, cleft palate, and choanal atresia) or FOXN1 (alopecia and T cell immunodeficiency) have an autosomal recessive inheritance (Clifton-Bligh et al., 1998; Frank et al., 1999) , and FOXP3 mutations [immune dysregulation, polyendocrinopathy, enteropathy (IPEX) syndrome] are X-linked (Bennett et al., 2001; Ramsdell et al., 2001) . However, FOXC1, -C2, -E3, -L2, and -P2 exhibit an autosomal dominant mode of inheritance, presumably due to haploinsufficiency, which indicates that gene dosage is critical for normal development. Interestingly, FOXC1 causes eye malformations, not only when the gene dosage is decreased, but also when it is increased due to chromosomal duplications (Lehmann et al., 2000; Nishimura et al., 2001) . This is one of only three known examples where duplication and deletion of a single gene both cause disease, which further emphasizes the importance of precise control of forkhead gene expression levels in eye development (Caplen, 2001) . The reason for the widespread sensitivity to alterations in gene dosage in the forkhead family can only be speculated on, but recent data on the C. elegans Pha-4 gene in pharynx development suggest a possible mechanism (Gaudet and Mango, 2002) . PHA-4 controls transcription of many pharyngeal genes directly, and the concentration of PHA-4 increases gradually during pharynx morphogenesis and differentiation. The relative affinity for PHA-4 of binding sites in promoters of pharyngeal genes appears to correlate primarily with the time point for onset of transcription and not with expression level. In complex morphogenetic processes where several cell types are involved, such as eye development, precise timing of gene activation is crucial. Changes in expression level of a transcription factor, caused by an altered gene dosage, may therefore result in premature or delayed activation of target genes and force morphogenetic processes out of step.
Tumor Diseases
The oncogene Qin of avian sarcoma virus 31 (ASV-31) is responsible for the transforming activity of the virus (Li and Vogt, 1993; reviewed by Vogt et al., 1997) . Its cellular counterpart, FoxG1, as well as the viral protein inhibit transcription of target genes, but the viral protein is a more potent repressor Li et al., 1995) . The colocalization of transforming and repressing domains in Qin suggests that this protein induces oncogenic transformation by down-regulating the expression of anti-mitotic genes (Li et al., 1995) .
A majority of chromosomal translocations that cause acute lymphoid leukemia (ALL) disrupt the gene encoding the transcription factor MLL (McCabe et al., 1992) . The oncogenic proteins that result from such chromosomal breaks are often fusion proteins consisting of the DNAbinding domain of MLL fused to the trans-activation domain of another transcription factor. Two of those factors are the forkhead proteins FOXO3 and FOXO4 (Borkhardt et al., 1997; Hillion et al., 1997; Parry et al., 1994) .
In alveolar rhabdomyosarcomas, chromosomal translocations generate chimeric transcripts that fuse the PAX3 or PAX7 DNA-binding domain with the trans-activation domain of FOXO1 (reviewed by Barr, 2001; Galili et al., 1993) . The chimeric proteins retain PAX3/PAX7 DNA binding specificity, but are more potent transcriptional activators than the wild-type proteins (Bennicelli et al., 1999; Fredericks et al., 1995; Sublett et al., 1995) . The fusion proteins are therefore believed to function as oncogenic transcription factors mainly through enhanced activation of normal PAX3/PAX7 targets. There are, however, indications that the specificity may also be altered; the PAX3-FOXO1 fusion protein upregulates the gene encoding the PDGF␣ receptor, although this gene is not normally a target for FOXO1 or PAX3 (Epstein et al., 1998) . The PDGF␣ receptor is a potent activator of PI3K (Porter and Vaillancourt, 1998 ), which in turn will inactivate FOXO proteins by inducing a shift in their subcellular localization. FOXO4 blocks cell cycle progression by activating the Cdk-inhibitor p27 kip1 , and inactivation of FOXO4 stimulates proliferation (Medema et al., 2000) . FOXO1 and FOXO3 have been shown to regulate apoptosis (Brunet et al., 1999; Dijkers et al., 2000; Tang et al., 1999) . The transforming potential of the PAX3-FOXO1 fusion protein could therefore, at least in part, be due to its ability to indirectly inactivate native FOXO proteins.
CONTROL OF METABOLISM AND GENE EXPRESSION IN DIFFERENTIATED TISSUES
Many metazoan forkhead genes that control morphogenesis or differentiation in the embryo have distinct functions in the adult. In particular, metabolic processes, including glucose, lipid, and energy homeostasis, appear to be controlled by members of this gene family. As a majority of forkhead null mutants in mice are embryonically lethal, much of our understanding of target gene regulation in differentiated tissues is based on transient transfections in cell lines, in vitro DNA binding assays, etc., but recently the use of transgenic mice and conditional knockouts have provided new insights.
The most extensively studied are the FoxA proteins and their roles in liver, lung, and pancreas metabolism (reviewed by Costa et al., 2001; Kaestner, 2000) . FoxA1-A3 were discovered as proteins binding to the ␣1-antitrypsin and transthyretin promoters (Costa et al., 1989) . Subsequently, FoxA binding sites have been discovered in regulatory regions of more than 100 genes expressed in liver, pancreas, lung, and intestine. These putative target genes include hepatic and pancreatic enzymes, surfactant proteins, serum proteins, and hormones (Cereghini, 1996; Costa et al., 2001; Kaestner, 2000) .
Foxa2-deficient embryos do not develop beyond E8.5 (Ang and Rossant, 1994; Weinstein et al., 1994) , and even chimeric embryos obtained from tetraploid embryo/ Foxa2 Ϫ/Ϫ ES cell aggregates lacked foregut and midgut endoderm . Hence, the null mutant cannot be used to investigate the role of Foxa2 in organogenesis or metabolism. Instead, the function of Foxa2 was studied in visceral endoderm of embryoid bodies; an in vitro system that mimics fetal liver and pancreas (Duncan et al., 1998) . In this model, lack of Foxa2 resulted in reduction of the mRNA levels for the POU-homeodomain transcription factor HNF-1␣ and the orphan nuclear receptor HNF-4␣, and in loss of mRNA for Foxa1 as well as for serum lipoproteins. This result suggests that Foxa2 regulates a transcription factor network required for differentiation and metabolism in early liver and pancreas. However, a conditional knockout inactivating Foxa2 specifically in hepatocytes toward the end of fetal development did not interfere with normal liver function or the overall hepatic transcriptional program (Sund et al., 2000) . Thus, Foxa2 seems to play a critical role in early liver development, but not to be required for maintenance of adult hepatocyte function. Deletion of Foxa2 in pancreatic ␤-cells, on the other hand, results in hyperinsulinemic hypoglycemia, which demonstrates that Foxa2 is involved in control of insulin secretion in the differentiated pancreas . The genes encoding both subunits of the ␤-cell ATP-sensitive K(ϩ) channel [K(ATP)]-the most frequently mutated genes in familial hyperinsulinism in man-were identified as Foxa2 targets in islets .
Mice homozygous for a Foxa3 null mutation develop normally and are fertile (Kaestner et al., 1998) . The expression of several putative FoxA target genes in liver (phosphoenolpyruvate carboxykinase, transferrin, tyrosine amino-transferase) was reduced by 50 -70%, indicating that Foxa3 is an activator of these genes in vivo. The status quo in mRNA levels of other hepatic genes-implicated as Foxa3 targets by in vitro assays-could be explained by compensatory binding of Foxa1 and Foxa2, the levels of which are increased in Foxa3 Ϫ/Ϫ mice (Kaestner et al., 1998) . When fasted, Foxa3 Ϫ/Ϫ mice exhibit a substantial drop in blood glucose, in spite of normal secretion of pancreatic hormones and upregulation of gluconeogenic enzymes (Shen et al., 2001) . Hepatic expression of the plasma membrane glucose transporter GLUT2 is significantly decreased in the mutant, which suggests that the hypoglycemia is caused by inefficient efflux of newly synthesized glucose from hepatocytes.
Hypoglycemia is seen also in Foxa1 Ϫ/Ϫ mice, which die soon after birth with severe growth retardation. In this case, the hypoglycemia derives from a marked reduction in circulating levels of the gluconeogenetic hormone glucagon, which correlates with a 50 -70% decrease in pancreatic islet mRNA levels for proglucagon (Kaestner et al., 1999; Shih et al., 1999) .
Another example, which illustrates the functional switch from embryonic morphogenerator to adult, metabolic regulator, is FoxC2. As described above, FoxC2 controls multiple aspects of mesoderm differentiation; null mice die in utero from vascular, skeletal, and kidney defects, and haploinsufficiency in man causes eye and lymphatic defects. In adults, however, high level expression of FoxC2 is restricted to adipocytes (Cederberg et al., 2001) . Transcriptional regulation of Foxc2 by insulin and TNF␣ and a selective hypoplasia of brown adipose tissue (BAT) in Foxc2 ϩ/Ϫ mice suggested that this gene is involved in controlling the balance between energy storage and dissipation. Transgenic overexpression of FOXC2 in brown and white adipose tissue (WAT) has a remarkably pleiotropic effect on the gene expression profile (Cederberg et al., 2001) . Expression of the BAT-specific uncoupling protein is induced in WAT, which exhibits increases in lipolysis, mitochondrial content, and oxygen consumption. Circulating levels of free fatty acids, triglycerides, glucose and insulin are reduced, insulin sensitivity is enhanced and total body fat content is decreased. FoxC2 appears to regulate metabolic efficiency in response to the energy content of the diet; a high-fat diet upregulates Foxc2 expression and induces less weight gain in the transgenic animals than in normal controls. An important mechanism behind many of these effects appears to be increased sensitivity to ␤-adrenergic stimuli, caused by an isoenzyme shift in adipocyte PKA holoenzyme, which lowers the threshold concentration required for PKA activation. Elevated expression of FoxC2 thus counteracts most symptoms associated with obesity which predisposes to insulin resistance and type 2 diabetes.
The role of proteins in the FoxO subfamily in insulin/IGF signaling, discussed above, is another example of control of glucose and energy metabolism by forkhead proteins.
CONCLUSIONS AND FUTURE PERSPECTIVES
As should be evident from this overview, there is no simple answer to the question of what forkhead proteins do. If a unifying theme is to be found, it is likely to be in the mechanisms of interaction with chromatin and the transcription machinery, although studies of many more proteins will be needed to confirm this. A reasonable assumption is that the first forkhead genes arose in unicellular, or very simple multicellular, organisms and that their function was in fundamental cell metabolism. This pattern is seen today in Fkh1 and -2 in yeast, and in mammalian FoxO and -M1 genes, which are ubiquitously expressed and involved in cell cycle and growth regulation. In sequence alignments, these genes represent outgroups in the forkhead family, which supports their anciennity. The metazoan forkhead main group, on the other hand, appears to have undergone a more recent expansion, presumably linked to the evolving anatomical complexity of animal body plans. Members of this group have tissue-specific expression patterns and are in general involved in cell-type determination and differentiation. A typical example is the subdivision of mesoderm in distinct populations, each expressing their characteristic subset of forkhead genes. In the differentiation process, forkhead proteins are often involved in sustaining proliferation of determined precursor cells, as well as in expression of differentiated traits. In many cases, genes responsible for differentiation processes during embryonic development are later recycled and control metabolism in the adult. At the sequence level, a strong conservation of the DNA binding domain often contrasts with an extensive divergence in other regions, indicating that the forkhead domain is compatible with multiple arrangements of transcriptional effector or signal transduction domains.
The number of forkhead genes for which we have loss-offunction data has increased dramatically in the last 5 years, and within the next 5 we can expect to have some kind of description of the mutant phenotype of all forkhead genes in the major model organisms. The next challenges will be to resolve issues of functional redundancy by creating combined mutants and overcome embryonic lethality with conditional knockouts to analyze functions in later stages or adults. In these exciting areas, the first papers have just recently been published. Another important subject will be to analyze in greater depth the mechanisms of transcriptional control, interactions with chromatin modifying enzymes, signal transducing molecules, etc. A better understanding of the molecular mechanisms of target gene interactions and transcriptional regulation may explain why the expression level (gene dosage) is so critical for many developmental processes in which forkhead proteins are involved.
